CorMedix (CRMD) Tops Q3 EPS by 4c

CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance